Article
Development and pilot testing of a prostate cancer polygenic risk report.
BMC medical genomics - 30 Jul 2026
Griffin Julia N, Danowski Morgan E, Gerety Haley L, Lafferty Katherine, Clayman Marla L, Antwi Ashley A, Bertero Mercedes G, Brunette Charles A, Gillespie Chris, Guentert Louise, Lennon Niall J, Martin Julian, Patel Lauren S, Vassy Jason L
Abstract excerpt
BACKGROUND: Polygenic risk scores (PRS) are increasingly being incorporated into clinical care, yet optimal strategies for communicating PRS results to patients and clinicians remain undefined. Effective report design is critical to ensure comprehension and appropriate use, particularly for complex conditions such as prostate cancer where screening decisions are nuanced. We developed and pilot tested...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
